A Phase Ⅰb/Ⅱa Clinical Study of IMC-003 Injection for the Treatment of Pulmonary Arterial Hypertension Receiving Background Therapy.

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Pulmonary Arterial Hypertension PAH

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
Study leads
  • Zhicheng Jing, M.D.

    Principal Investigator

    Guangdong Provincial People's Hospital